Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+4.7%
5Y CAGR+5.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+4.7%/yr
vs +6.8%/yr prior
5Y CAGR
+5.0%/yr
Consistent
Acceleration
-2.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $85.84M | +16.1% |
| 2024 | $73.91M | +0.2% |
| 2023 | $73.74M | -1.4% |
| 2022 | $74.77M | +22.7% |
| 2021 | $60.93M | -9.4% |
| 2020 | $67.23M | -2.4% |
| 2019 | $68.85M | +19.6% |
| 2018 | $57.56M | +32.6% |
| 2017 | $43.41M | +5.4% |
| 2016 | $41.20M | - |